arrow
D

Daniel Lindén

eberhard karls university of tubingen
H指数:37
被引数:4,254
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Downregulation of the MARC1 p.A165 risk allele reduces hepatocyte lipid content by increasing beta-oxidation

MARC1 p.A165风险等位基因的下调通过增加β-氧化来减少肝细胞脂质含量。

2024-12-232
OA
An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)

基于与人类代谢功能障碍相关的脂肪变性肝病 (MASLD) 的接近程度,对小鼠饮食模型进行无偏排名

2024-06-1233
OA
Early macrophage response to obesity encompasses Interferon Regulatory Factor 5 regulated mitochondrial architecture remodelling
2022-08-309
OAAI
Modelling human liver fibrosis in the context of non-alcoholic steatohepatitis using a microphysiological system

使用微生理系统在非酒精性脂肪性肝炎的背景下模拟人类肝纤维化

2021-09-1527
OAAI
Suppression of insulin-induced gene 1 (INSIG1) function promotes hepatic lipid remodelling and restrains NASH progression

抑制胰岛素诱导基因1 (INSIG1) 功能促进肝脂质重塑并抑制NASH进展

2021-06-0132
OAAI
An oral antisense oligonucleotide for PCSK9 inhibition
2021-05-1289
PRE
PCSK9 rs11591147 R46L loss-of-function variant protects against liver damage in individuals with NAFLD
2020-11-0234
PREAI